BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24800242)

  • 1. MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization.
    Omrane I; Kourda N; Stambouli N; Privat M; Medimegh I; Arfaoui A; Uhrhammer N; Bougatef K; Baroudi O; Bouzaienne H; Marrakchi R; Bignon YJ; Benammar-Elgaaied A
    Biomed Res Int; 2014; 2014():584852. PubMed ID: 24800242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune microenvironment of the colorectal tumor: Involvement of immunity genes and microRNAs belonging to the TH17 pathway.
    Omrane I; Benammar-Elgaaied A
    Biochim Biophys Acta; 2015 Aug; 1856(1):28-38. PubMed ID: 25911397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
    Wang M; Zhang P; Li Y; Liu G; Zhou B; Zhan L; Zhou Z; Sun X
    Med Oncol; 2012 Dec; 29(5):3113-8. PubMed ID: 22562822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway.
    Cao J; Zhang K; Zheng J; Dong R
    Mol Med Rep; 2015 Apr; 11(4):2889-95. PubMed ID: 25523239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
    Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
    BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal MicroRNAs as novel biomarkers for colon cancer screening.
    Link A; Balaguer F; Shen Y; Nagasaka T; Lozano JJ; Boland CR; Goel A
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1766-74. PubMed ID: 20551304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
    Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
    IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas.
    Prabowo AS; van Scheppingen J; Iyer AM; Anink JJ; Spliet WG; van Rijen PC; Schouten-van Meeteren AY; Aronica E
    J Neuroinflammation; 2015 May; 12():97. PubMed ID: 25986346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as biomarkers in colorectal cancer diagnosis and prognosis.
    Ju J
    Bioanalysis; 2010 May; 2(5):901-6. PubMed ID: 20543966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: Critical issues to discern between modulatory effects and potential artefacts.
    Nuñez-Sánchez MA; Dávalos A; González-Sarrías A; Casas-Agustench P; Visioli F; Monedero-Saiz T; García-Talavera NV; Gómez-Sánchez MB; Sánchez-Álvarez C; García-Albert AM; Rodríguez-Gil FJ; Ruiz-Marín M; Pastor-Quirante FA; Martínez-Díaz F; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Mol Nutr Food Res; 2015 Oct; 59(10):1973-86. PubMed ID: 26105520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of microRNA-16 expression in human colorectal cancer.
    Qian J; Jiang B; Li M; Chen J; Fang M
    World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as promising biomarkers for tumor-staging: evaluation of MiR21 MiR155 MiR29a and MiR92a in predicting tumor stage of rectal cancer.
    Yang Y; Peng W; Tang T; Xia L; Wang XD; Duan BF; Shu Y
    Asian Pac J Cancer Prev; 2014; 15(13):5175-80. PubMed ID: 25040971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating exosomal microRNAs as biomarkers of colon cancer.
    Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
    PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.
    Olaru AV; Selaru FM; Mori Y; Vazquez C; David S; Paun B; Cheng Y; Jin Z; Yang J; Agarwal R; Abraham JM; Dassopoulos T; Harris M; Bayless TM; Kwon J; Harpaz N; Livak F; Meltzer SJ
    Inflamm Bowel Dis; 2011 Jan; 17(1):221-31. PubMed ID: 20848542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer.
    Bahreini F; Saidijam M; Mousivand Z; Najafi R; Afshar S
    Mol Biol Rep; 2021 Apr; 48(4):3541-3547. PubMed ID: 33956301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.
    Vickers MM; Bar J; Gorn-Hondermann I; Yarom N; Daneshmand M; Hanson JE; Addison CL; Asmis TR; Jonker DJ; Maroun J; Lorimer IA; Goss GD; Dimitroulakos J
    Clin Exp Metastasis; 2012 Feb; 29(2):123-32. PubMed ID: 22120473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.